Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Early use of J&J's Zytiga extends prostate cancer survival
Early use of J&J's Zytiga extends prostate cancer survival
Early use of J&J's Zytiga extends prostate cancer survival
Submitted by
admin
on June 4, 2017 - 11:46am
Source:
Yahoo/Reuters
News Tags:
JNJ
Zytiga
prostate cancer
ASCO 2017
Headline:
Early use of J&J's Zytiga extends prostate cancer survival
Do Not Allow Advertisers to Use My Personal information
